Odin

Odin Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of complex generic injectable and ophthalmic products. The company maintains a diverse portfolio of FDA-approved products and a robust pipeline of abbreviated new drug applications (ANDAs) targeting high-barrier-to-entry markets. Odin leverages its expertise in formulation and regulatory affairs to bring cost-effective alternatives to market for critical care and specialty medicine. Headquartered in New Jersey, the company operates within the generic pharmaceutical sector, emphasizing quality and supply chain reliability for healthcare providers.